Upexi, Inc.
NASDAQ:UPXIInternet Content & Information
-$0.04 today
- Market cap
- $51.54M
- Beta
- -0.33
- P/E (TTM)
- -0.3
- EPS (TTM)
- -$3.49
Volume 0.93M
Average 3.19M
UPXI Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Upexi, Inc.NASDAQ: UPXI
Capital Expenditures · Q3 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q3 FY2026 capital expenditures of $11.73K (cash outflow) fell 61.7% year over year, behind the -56.9% change in trailing-twelve-month capital expenditures. Over 3 fiscal years it compounded at -60.2% a year.
Context
- Capital expenditures amounted to 2.5% of revenue in FY2025, down 1.1 pp from a year earlier.
- Capital expenditures grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -61.7% toward the trailing-twelve-month pace of -56.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (387.76K) USD
- Year-over-year change
- +58.4%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | (387.76K) | +58.4% |
| FY2024 | 2024-06-30 | (932.56K) | +0.5% |
| FY2023 | 2023-06-30 | (937.56K) | +84.8% |
| FY2022 | 2022-06-30 | (6.15M) | -332.8% |
| FY2021 | 2021-06-30 | (1.42M) | — |
Capital Expenditures vs competitors
How UPXI compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -56.9% is the 8th highest of 9, against a peer median of -6.2%.
- Capital expenditures amounts to 0.8% of revenue for UPXI, versus a peer median of 1.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $90.21M USD | -5.2% | -17.6% | 12.3% | |
| LTM Mar 2026 | $44.68M USD | -7.2% | +0.6% | 2.1% | |
| LTM Mar 2026 | $20.96M USD | -8.9% | -18.3% | 1.6% | |
| LTM Mar 2026 | $8.74M USD | +64.7% | +18.9% | 7.1% | |
| LTM Mar 2026 | $8.13M USD | -2.8% | -14.6% | 1.5% | |
| LTM Mar 2026 | €4.5M EUR | +41.5% | +4.3% | 0.8% | |
| LTM Mar 2026 | $201.49K USD | -56.9% | -60.2% | 0.8% | |
| LTM Mar 2026 | $25K USD | -67.5% | -7.8% | 0.0% | |
| LTM Mar 2026 | $18K USD | -33.3% | -60.4% | 0.0% | |
| LTM Dec 2025 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UPXI) | — | -6.2% | -11.2% | 1.5% | |
Competitors are the stored peer set for UPXI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | 2.98M | (2.1M) | (16.93M) | (25.27M) | (13.68M) |
| Depreciation & Amortization | 1.03M | 2.73M | 3.54M | 3.68M | 757.76K |
| Deferred Income Tax | (1.28M) | (1.06M) | 0 | (344.8K) | 0 |
| Stock-Based Compensation | 611.43K | 3.33M | 3.66M | 0 | 2.11M |
| Change in Working Capital | (521.93K) | (3.31M) | (1.44M) | 2.89M | 1.93M |
| Accounts Receivables | (1.14M) | (17.31K) | (364.67K) | 675.71K | (484.58K) |
| Inventory | (846.66K) | (2.45M) | (1.37M) | 2.65M | (470.19K) |
| Accounts Payables | 1.97M | (430.51K) | 389.46K | (944.02K) | 2.87M |
| Other Working Capital | (503.85K) | (411.33K) | 292.04K | 509.97K | 20.87K |
| Other Non-Cash Items | 123.65K | 924.9K | 11.36M | 18.94M | 465.19K |
| Operating Cash Flow | 2.94M | 521.87K | 202.68K | (101.38K) | (8.42M) |
| Capital Expenditures | (1.42M) | (6.15M) | (937.56K) | (932.56K) | (387.76K) |
| Acquisitions (Net) | 62.12K | (5.46M) | (4.58M) | 1.56M | 6.01M |
| Purchases of Investments | 0 | (1.03M) | 0 | 0 | (104.91M) |
| Sales of Investments | 0 | 1.03M | 0 | 0 | 0 |
| Other Investing Activities | 79K | 6K | 2.94M | (4M) | 0 |
| Investing Cash Flow | (1.28M) | (11.61M) | (2.57M) | (3.38M) | (99.29M) |
| Debt Repayment | 988.08K | 5.68M | (1.56M) | (353.79K) | 16.9M |
| Common Stock Issued | 10.95M | 0 | 0 | 0 | 93.13M |
| Common Stock Repurchased | 0 | (1.98M) | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 1.28M | 0 | 0 |
| Financing Cash Flow | 11.99M | 3.7M | (285.33K) | (353.79K) | 110.03M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 13.65M | (7.38M) | (2.66M) | (3.83M) | 2.31M |
| Free Cash Flow | 1.52M | (5.63M) | (734.89K) | (1.03M) | (8.81M) |
Upexi, Inc.
NASDAQ:UPXI
Intrinsic Alpha fair value
Locked
Current Price
$0.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.